Prednisolone reduces sequelae in Bell’s Palsy
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Patients treated for Bell palsy with prednisolone within 72 hours achieved significantly reduced severity of mild to… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Patients treated for Bell palsy with prednisolone within 72 hours achieved significantly reduced severity of mild to… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Patients treated for Bell palsy with prednisolone within 72 hours achieved significantly reduced severity of mild to… read more.
by Thomas R. Collins – With a scarcity of livers available for transplantation, there is a tremendous pressure on the medical community to make the best use of… read more.
Mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder appear to be highly associated with non-medical prescription opioid use.
by Bruce Sylvester – Women with breast pain who undergo extra-routine mammograms, MRIs or ultrasounds as part of breast pain evaluation derive no diagnostic or therapeutic benefit, researchers… read more.
Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.
Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Heart disease patients who use statins are significantly less likely to develop depression than their counterparts who… read more.
Pictured: Dr. Yael P. Mosse is a pediatric oncologist at The Children’s Hospital of Philadelphia. Children’s Hospital of Philadelphia researcher leads trial of ALK inhibitor in neuroblastoma, lymphoma. … read more.
Patients with advanced chronic obstructive pulmonary disease (COPD) and shortness of breath found that opioids provided relief and improved their quality of life,
Troublesome dyspnoea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
The majority of patients with chronic obstructive pulmonary disease (COPD) referred for pulmonary rehabilitation have multiple extra-pulmonary comorbidities, according to a new study from the Netherlands.
Skin cell target for pain discovered using novel translational research platform.